COMP <GO>
RHI vs PG // REVENUE GROWTH (YOY)
Robert Half Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: RHI 4
— PG 10
▲ REVENUE GROWTH (YOY) LEADER: PG
LAST: $43.73 (+2.17%) • MKT CAP: $4.38B
revenue-growth
-7.20%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
revenue-growth
0.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RHI VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RHI | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 37.20% | 51.20% | -14.00 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.10% | 25.40% | -21.30 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.7x | 16.2x | +21.50 | PG | /valuation <GO> |
| Free Cash Flow Yield | 6.09% | 3.77% | +2.32 | RHI | /fcf-yield <GO> |
| Operating Margin | 1.40% | 24.30% | -22.90 | PG | /operating-margins <GO> |
| Net Profit Margin | 2.50% | 19.00% | -16.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -7.20% | 0.30% | -7.50 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.44% | 2.65% | +2.79 | RHI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.94 | 5.59 | -1.65 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.50% | +0.20 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.2 | 62.7 | +2.54 | RHI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.87 | +0.06 | RHI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.6x | 21.7x | +8.90 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.38B | $372.21B | -$367.83B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RHI REV | PG REV | RHI GROSS % | PG GROSS % | RHI FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.38B | $84.28B | 37.2% | 51.2% | $266.8M | $14.04B |
| FY 2024 | $5.80B | $84.04B | 38.8% | 51.4% | $354.2M | $16.52B |
| FY 2023 | $6.39B | $82.01B | 44.0% | 44.0% | $349.2M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RHI // BETA 0.93
PG // BETA 0.87